Skip to content

THERALINK TECHNOLOGIES, INC.: 10-Q filed 2023-05-15

What THERALINK TECHNOLOGIES, INC. reported in its quarterly report filed 2023-05-15 (fiscal Q2 2023): 38 published measures, 106 facts as tagged in accession 0001493152-23-017352.

This filing

Form
10-Q (quarterly report)
Filed
2023-05-15
Fiscal period
fiscal Q2 2023
Accession
0001493152-23-017352 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THERALINK TECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-03-312,247,015USD
At 2022-09-302,598,911USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-03-3154,579,251USD
At 2022-09-306,399,966USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-03-31-52,332,236USD
At 2022-12-31-44,302,919USD
At 2022-09-30-6,801,055USD
At 2022-03-31-3,918,693USD
At 2021-12-31-4,865,914USD
At 2021-09-30-4,945,362USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-8,566,382USD90
2022-10-01 to 2023-03-31-45,022,729USD182
2022-10-01 to 2022-12-31-36,456,347USD92
2022-01-01 to 2022-03-31-1,835,995USD90
2021-10-01 to 2022-03-31-3,348,262USD182
2021-10-01 to 2021-12-31-1,512,267USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-10-01 to 2023-03-31-3,517,969USD182
2021-10-01 to 2022-03-31-2,819,675USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-10-01 to 2023-03-317,980USD182
2021-10-01 to 2022-03-314,711USD182

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-01-01 to 2023-03-31169,787USD90
2022-10-01 to 2023-03-31225,082USD182
2022-01-01 to 2022-03-3119,500USD90
2021-10-01 to 2022-03-3198,475USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-10-01 to 2023-03-313,340,411USD182
2021-10-01 to 2022-03-312,957,702USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-10-01 to 2023-03-31-7,980USD182
2021-10-01 to 2022-03-31-4,711USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-03-31-107,869,998USD
At 2022-09-30-62,807,817USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-01-01 to 2023-03-316,151,499,919shares90
2022-10-01 to 2023-03-316,151,499,846shares182
2022-01-01 to 2022-03-315,596,220,371shares90
2021-10-01 to 2022-03-315,715,133,330shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-01-01 to 2023-03-310USD/shares90
2022-10-01 to 2023-03-31-0.01USD/shares182
2022-01-01 to 2022-03-310USD/shares90
2021-10-01 to 2022-03-310USD/shares182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-03-31612,595USD
At 2022-09-30686,127USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-03-31537,065USD90
2022-10-01 to 2023-03-311,149,238USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-2,146,254USD90
2022-10-01 to 2023-03-31-4,722,044USD182
2022-01-01 to 2022-03-31-1,560,293USD90
2021-10-01 to 2022-03-31-2,942,309USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-03-31444,077USD
At 2022-09-30646,984USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-01-01 to 2023-03-314,892,017USD90
2022-10-01 to 2023-03-316,739,052USD182
2022-01-01 to 2022-03-31267,202USD90
2021-10-01 to 2022-03-31402,853USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-03-3153,422,393USD
At 2022-09-303,455,720USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-03-3140,610USD
At 2022-09-3032,125USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-01-01 to 2023-03-312,290,615USD90
2022-10-01 to 2023-03-314,910,882USD182
2022-01-01 to 2022-03-311,562,613USD90
2021-10-01 to 2022-03-312,980,039USD182

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-01-01 to 2023-03-31144,361USD90
2022-10-01 to 2023-03-31188,838USD182
2022-01-01 to 2022-03-312,320USD90
2021-10-01 to 2022-03-3137,730USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-01-01 to 2023-03-3125,426USD90
2022-10-01 to 2023-03-3136,244USD182
2022-01-01 to 2022-03-3117,180USD90
2021-10-01 to 2022-03-3160,745USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-03-316,151,499,919shares
At 2022-09-306,151,499,919shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-03-3154,922,612USD
At 2022-09-3055,391,612USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-03-311,129,858USD
At 2022-09-301,154,861USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2023-03-311,171,181USD
At 2022-09-301,183,312USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-03-311,051,922USD
At 2022-09-301,043,942USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-03-31439,327USD
At 2022-09-30357,815USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-03-31308,712USD
At 2022-09-30268,021USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-03-31194,645USD
At 2022-09-30217,699USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2023-03-31274,515USD
At 2022-09-30156,550USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-8,566,382USD90
2022-10-01 to 2023-03-31-45,062,181USD182
2022-01-01 to 2022-03-31-1,895,174USD90
2021-10-01 to 2022-03-31-3,467,934USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-01-01 to 2023-03-31422,987USD90
2022-10-01 to 2023-03-31871,480USD182
2022-01-01 to 2022-03-31523,264USD90
2021-10-01 to 2022-03-311,060,920USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-10-01 to 2023-03-31104,696USD182
2021-10-01 to 2022-03-3195,113USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-6,420,128USD90
2022-10-01 to 2023-03-31-40,300,685USD182
2022-01-01 to 2022-03-31-275,702USD90
2021-10-01 to 2022-03-31-405,953USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-10-01 to 2023-03-316,243USD182
2021-10-01 to 2022-03-3158,052USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-10-01 to 2023-03-3115,985USD182
2021-10-01 to 2022-03-31137,038USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-10-01 to 2023-03-31-105,797USD182
2021-10-01 to 2022-03-31-87,201USD182

Inspect the source

Entity
THERALINK TECHNOLOGIES, INC. / CIK 0001362703
Captured
SEC response SHA-256
8ea68b29937a9dc79f3f437bfa115ba2d25bc4aa61d4ac37350bf0c10a93ef12

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001362703.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))